Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma – the GlioCave study (NOA 17 – ARO 2016/3 – DKTK ROG trial)

Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma – the GlioCave study (NOA 17 – ARO 2016/3 – DKTK ROG trial)

Abstract Background Glioblastoma relapses in the vast majority of cases within 1 year. Maximum safe resection of the recurrent glioblastoma can be offered in some cases. Re-irradiation has been established for the treatment of recurrent glioblastoma, too. In both cases, adjuvant treatment, mostly us...

Full description

Bibliographic Details
Main Authors: Christoph Straube, Hagen Scherb, Jens Gempt, Jan Kirschke, Claus Zimmer, Friederike Schmidt-Graf, Bernhard Meyer, Stephanie E. Combs
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Cancer
Subjects:
Glioblastoma
Recurrence
Re-irradiation
Gross total resection
Randomized trial
NOA
Online Access:http://link.springer.com/article/10.1186/s12885-017-3928-7

Internet

http://link.springer.com/article/10.1186/s12885-017-3928-7

Similar Items